SYK - Stryker Corporation
| Previous Close | 180.24 |
| Open | 180.08 |
| Bid | 180.20 x 1300 |
| Ask | 180.24 x 1100 |
| Day's Range | 174.84 - 180.83 |
| 52 Week Range | 144.75 - 199.85 |
| Volume | 3,306,596 |
| Avg. Volume | 1,375,904 |
| Market Cap | 67.256B |
| Beta (3Y Monthly) | 1.04 |
| PE Ratio (TTM) | 19.30 |
| EPS (TTM) | 9.34 |
| Earnings Date | Apr 23, 2019 |
| Forward Dividend & Yield | 2.08 (1.05%) |
| Ex-Dividend Date | 2019-03-28 |
| 1y Target Est | 197.67 |
- Zacks•19 hours ago
Varian Medical (VAR) to Report Q2 Earnings: What's in Store?
Varian Medical (VAR) expects to gain significantly from APAC and EMEA regions in fiscal Q2.
- Simply Wall St.•21 hours ago
What Can We Expect From Stryker Corporation's (NYSE:SYK) Earnings In The Year Ahead?
Looking at Stryker Corporation's (NYSE:SYK) earnings update in December 2018, analyst consensus outlook appear pessimistic, with...
- Zacks•2 days ago
Can Core MedSurg Segment Drive Stryker's (SYK) Q1 Earnings?
Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine along with an upbeat 2019 view are likely to support Stryker (SYK) in Q1. But integration risks might be a dampener.
- Zacks•2 days ago
Can Five Elements Drive Quest Diagnostics (DGX) Q1 Earnings?
Quest Diagnostics (DGX) seems in sync with its strategy to expedite growth and operational excellence.
- Zacks•2 days ago
What's in Store for Edwards Lifesciences' (EW) Q1 Earnings?
Edwards Lifesciences (EW) expects to gain from core Critical Care product group in Q1.
- Zacks•2 days ago
Stryker's LIFEPAK CR2 Defibrillator Launch to Boost MedSurg
Stryker's (SYK) emergency care department offers a broad range of products and systems.
- Zacks•3 days ago
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth
Stryker (SYK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•3 days ago
Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?
Despite ongoing customers' transition from HiSeq consumables to NovaSeq, Illumina's (ILMN) Q1 results are expected to gain from this high throughput suite.
- Zacks•4 days ago
Can Medical Devices Strength Drive Abbott (ABT) Q1 Earnings?
Abbott (ABT) expects high single-digit growth in Medical Devices' sales in first-quarter 2019 and continued double-digit growth in certain sub-segments.
- Zacks•7 days ago
Top Analyst Reports for Bank of America, Amgen & NextEra Energy
Top Analyst Reports for Bank of America, Amgen & NextEra Energy
- Zacks•7 days ago
Medtronic's (MDT) Study Shows Positive Results of TDD Use (revised)
The outcomes of the study demonstrates that patients on TDD along with CMM witnessed some major benefits compared to those on CMM alone.
- Zacks•7 days ago
Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings?
Intuitive Surgical's (ISRG) Systems and Services revenues are likely to boost Q1 results.
- Zacks•8 days ago
ResMed's Brightree Widens ReSupply Solution Usage for HME
Resmed's (RMD) Brightree ReSupply is a scalable and automated solution that comprises live-agent inbound and outbound calls for more private interaction with patients and email reminder capabilities.
- Zacks•8 days ago
Here's Why Investors Should Retain Accuray (ARAY) Stock Now
Management at Accuray (ARAY) sees significant opportunities in China.
- Zacks•8 days ago
Walgreens Partners With VillageMD to Offer Primary Healthcare
This joint venture marks Walgreens' (WBA) commitment toward enabling access to affordable healthcare and creating neighborhood health destinations.
- Zacks•9 days ago
Medtronic's (MDT) Study Shows Positive Results of TDD Use
The outcomes of the study, conducted by Medtronic (MDT), demonstrates that patients on TDD along with CMM witnessed some major benefits compared to those on CMM alone.
- Zacks•9 days ago
Here's Why You Should Buy Varian Medical (VAR) Stock Now
Varian Medical (VAR) announces the installation of cyclotron for its ProBeam proton therapy system at the Hefei Ion Medical Center in China.
- Zacks•9 days ago
Walgreens' Weak Market Trends a Woe, Strategic Deals to Aid
Walgreens Boots (WBA) currently endeavors to redress certain areas of operational weakness and reinforces its managerial competence to drive operating efficiency with a resolute focus.
- Zacks•9 days ago
Medtronic (MDT) Inks Value-Based Deal for Guardian Connect
Medtronic's (MDT) Guardian Connect system can now be accessed via a Blue Cross and Blue Shield of Minnesota member's pharmacy benefit.
- Zacks•10 days ago
Varian Medical's (VAR) ProBeam Installed in China's HIMC
Varian Medical (VAR) has seen some notable developments in its Proton Therapy business in recent times.
- Zacks•10 days ago
Bio-Rad's (BIO) IH-500 System Secures 510(K) From the FDA
The regulatory go-ahead is in line with Bio-Rad's (BIO) strategy of strengthening in the transfusion medicine market of the United States.
- Zacks•11 days ago
Intersect ENT Grows on Product Launch Amid Pricing Pressure
Intersect ENT (XENT) recently finishes the ENCORE Study, which is a small 50-patient open label program, designed to evaluate the safety of the repeat use of SINUVA.
- Zacks•11 days ago
Natus Medical to Divest Medix for Focusing on Core Business
Per Natus Medical (BABY), this deal is strategically aligned with its business as besides concentrating on its core products, this sell-off will lead to planned investment in the high-growth markets.
- Zacks•11 days ago
5 ROE Stocks to Buy on Solid Jobs Data & Trade Deal Odds
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
- Zacks•11 days ago
Orthofix (OFIX) Reports Encouraging M6-C Disc Study Results
The primary goal of the study was to assess the safety and efficacy of Orthofix's (OFX) M6-C artificial cervical disc in comparison to ACDF treatment.
